Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamsulosin + Tadalafil for Ureteric Stent Related Symptoms
NCT07562282Recruiting
- Sponsor
- Ain Shams University
- Start
- Dec 2025
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of tadalafil (2 arms), sponsored by Ain Shams University. Primary endpoint: Evaluation of Ureteral Stent Symptoms at 4 weeks. Started Dec 2025; status: recruiting.
02
Drugs
tadalafil
Beyond the preview
Go deeper on NCT07562282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07562282.